The document calls for papers for a special issue of the Canadian Respiratory Journal on advanced monoclonal antibodies for asthma. It discusses how monoclonal antibodies may work through multiple mechanisms to treat asthma, including altering redox metabolites and regulating inflammatory proteins. It invites original research and review articles on targeted therapeutics for severe asthma using monoclonal antibodies against cytokines like IL-5, IL-17, and IL-13. Potential topics also include real-world data on monoclonal antibody therapy in asthma patients and the use of monoclonal antibodies in pregnant asthmatics or those with comorbidities. The deadline for manuscript submission is December 23, 2016.